ArticleFrontiers in pharmacology2022

Metabolomics profiling of AKT/c-Met-induced hepatocellular carcinogenesis and the inhibitory effect of Cucurbitacin B in mice.

Xiangyu Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.